Venous creatinine as a biomarker for loss of fat‐free mass and disease progression in patients with amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Venous creatinine as a biomarker for loss of fat‐free mass and disease progression in patients with amyotrophic lateral sclerosis

Published:2021-08-09 Issue:11 Volume:28 Page:3615-3625
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Euro J of Neurology

Author:

Holdom Cory J.¹²,Janse van Mantgem Mark R.³^ORCID,Eijk Ruben P. A.³⁴^ORCID,Howe Stephanie L.¹,Berg Leonard H.³,McCombe Pamela A.²⁵^ORCID,Henderson Robert D.²⁵^ORCID,Ngo Shyuan T.¹²⁵^ORCID,Steyn Frederik J.²⁵⁶^ORCID

Affiliation:

1. Australian Institute for Bioengineering and Nanotechnology The University of Queensland Brisbane QLD Australia

2. Centre for Clinical Research The University of Queensland Brisbane QLD Australia

3. Department of Neurology UMC Utrecht Brain Centre University Medical Centre Utrecht Utrecht the Netherlands

4. Biostatistics & Research Support Julius Centre for Health Sciences and Primary Care University Medical Centre Utrecht Utrecht the Netherlands

5. Department of Neurology Royal Brisbane and Women’s Hospital Brisbane QLD Australia

6. School of Biomedical Sciences The University of Queensland Brisbane QLD Australia

Funder

Cure for MND Foundation

University of Queensland

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.15003

Reference36 articles.

1. Amyotrophic Lateral Sclerosis

2. Assessing skeletal muscle mass: historical overview and state of the art

3. Total plasma creatinine: an accurate measure of total striated muscle mass

4. Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine

5. Amyotrophic Lateral Sclerosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase Angle and Bioelectrical Impedance Vector Analysis (BIVA) in Amyotrophic Lateral Sclerosis (ALS) Patients;Applied Sciences;2024-02-15

2. A comparison between bioelectrical impedance analysis and air-displacement plethysmography in assessing fat-free mass in patients with motor neurone diseases: a cross-sectional study;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2024-01-24

3. Cystatin C based estimation of chronic kidney disease and amyotrophic lateral sclerosis in the ALS registry Swabia: associated risk and prognostic value;Scientific Reports;2023-11-10

4. The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA);Scientific Reports;2023-10-12

5. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis;Journal of Neurology;2023-10-06